Precision Weight Management. Unmatched Value for Researchers
Product Overview
Cagrilintide is an innovative long-acting amylin analogue created by Novo Nordisk. This dual amylin and calcitonin receptor agonist introduces a new mechanism for weight management, equipping researchers with a powerful tool for studies on metabolic health.
Key Benefits
*Dual Receptor Activation: Effectively targets both amylin and calcitonin receptors to control appetite, improve satiety, and influence glucose metabolism.
*Clinically Proven Efficacy: Research has shown that Cagrilintide results in clinically meaningful, dose-dependent weight loss, with more significant reductions noted at higher doses.
*Enhanced Metabolic Health: Treatment with Cagrilintide is linked to substantial decreases in body weight and better metabolic parameters.
*Cost-Effective Research Tool: The 5mg vial provides a more economical choice for prolonged research protocols, lowering the cost per milligram compared to higher doses.
Composition
*Active Ingredient: Cagrilintide
*Concentration: 5mg per vial.
*Form: Lyophilized peptide powder.
Usage & Storage
Intended Use: For research purposes only
Storage: Keep the lyophilized powder in a cool, dry environment.
Once reconstituted, refrigerate at 2-8°C and utilize within the specified study timeframe.
